Catalyst
Slingshot members are tracking this event:
Pacira (PCRX) Expects Exparel Phase 3 Topline Data by end of 2016 (Femoral Nerve Block in Total Knee arthroplasty)
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
PCRX |
|
|
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 25, 2017
Occurred Source:
http://investor.pacira.com/phoenix.zhtml?c=220759&p=irol-newsArticle&ID=2288475
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Arthroplasty, Phase 3 Topline Data, Exparel, Q4 2016